Skip to main content
HIMS
NYSE Life Sciences

Hims Adds Lilly's Zepbound to Platform, Plans New Peptides After Guidance Cut

Tom Rudovsky · Reported by Wiseek News
More coverage: Household Product Stocks · Consumer
Sentiment info
Neutral
Importance info
7
Price
$18.999
Mkt Cap
$4.463B
52W Low
$13.74
52W High
$42.7
52W Position info
38% above low
Off High info
56% below high
Rel. Volume info
5.0× avg
Market data snapshot near publication time

HIMS sits 38% above its 52-week low of $13.74 on elevated volume (5.0× avg).

Summary

Hims agreed to offer Eli Lilly's Zepbound and Foundayo weight-loss treatments through its platform, with prescriptions available after a provider consultation. That is a notable shift for a company whose weight-loss business has been built on compounded GLP-1s, which face FDA warnings and an HHS interim access policy still under White House review. Separately, Hims plans November launches of glutathione, sermorelin and NAD+ products, with BPC-157 and TB-500 to follow subject to federal policy, and expects limited revenue from them this year. The backdrop is a rough quarter: Q3 revenue of $890.4 million rose 49% but missed estimates, the company posted a $33 million net loss, and it cut full-year EBITDA guidance, sending shares down more than 15%. The Lilly tie-up gives the platform a branded option as compounded supply rules tighten, but the new peptide lineup carries regulatory risk and won't move 2026 numbers.

At the time of this announcement, HIMS was trading at $19.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $4.5B. The 52-week trading range was $13.74 to $42.70. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

HIMS - Latest Insights

HIMS
Nov 10, 2026, 1:54 PM EST
Source: Benzinga
Importance Score:
8
Price at Filing: $18.85
Real-time Price: $19.39 info
Change: +$0.5499 (+3%) info
Market Cap: $4.463B info
HIMS
Nov 10, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $22.16
Real-time Price: $19.39 info
Change: -$2.77 (-12%) info
Market Cap: $4.463B info
HIMS
Nov 09, 2026, 5:52 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $22.33
Real-time Price: $19.39 info
Change: -$2.94 (-13%) info
Market Cap: $4.463B info
HIMS
Nov 09, 2026, 4:17 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $23.39
Real-time Price: $19.39 info
Change: -$4.00 (-17%) info
Market Cap: $4.463B info
HIMS
Nov 09, 2026, 4:13 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $22.18
Real-time Price: $19.39 info
Change: -$2.78 (-13%) info
Market Cap: $4.463B info